Published in J Gen Virol on July 01, 1998
Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus. J Gen Virol (2014) 0.91
Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses. Vaccine (2014) 0.91
Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus. PLoS One (2013) 0.88
An overview on ELISA techniques for FMD. Virol J (2011) 0.80
Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus. Virol J (2012) 0.79
Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa. Arch Virol (2013) 0.77
Tracking the Antigenic Evolution of Foot-and-Mouth Disease Virus. PLoS One (2016) 0.75
Molecular epidemiology of foot-and-mouth disease virus. Virus Res (2003) 3.62
Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science (1993) 2.85
Candidate for immunoglobulin D present on murine B lymphocytes. Nature (1974) 2.29
Immunoglobulin M biosynthesis. Intracellular accumulation of 7S subunits. Biochem J (1969) 2.24
Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J Immunol (1978) 1.99
Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes. J Gen Virol (2007) 1.84
Inhibition of spleen cell DNA synthesis by autologous macrophages. J Immunol (1966) 1.84
Singular phase nano-optics in plasmonic metamaterials for label-free single-molecule detection. Nat Mater (2013) 1.81
An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol (1996) 1.73
Assembly of immunoglobulin M. Blocked thiol groups of intracellular 7S subunits. Biochem J (1971) 1.53
Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. Vet Rec (2001) 1.52
Variation in caesarean and instrumental delivery rates in New Zealand hospitals. Aust N Z J Obstet Gynaecol (1995) 1.52
Immunoglobulin M biosynthesis. Production of intermediates and excess of light-chain in mouse myeloma MOPC 104E. Biochem J (1971) 1.51
Changing proteins on the surface of a parasitic nematode. Nature (1980) 1.50
Evidence for positive selection in foot-and-mouth disease virus capsid genes from field isolates. Genetics (2001) 1.49
Electron microscopic studies of mouse immunoglobulin M; structure and reconstitution following reduction. Immunology (1970) 1.48
Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice. J Exp Med (1977) 1.44
Preparation and properties of a cytotoxic monoclonal rat anti-mouse Thy-1 antibody. J Immunol Methods (1982) 1.43
A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41
Generation of immunoglobulin class diversity in b cells: a discussion with emphasis on idg development. Ann Immunol (Paris) (1976) 1.40
Preparation and characterisation of an antiserum to the mouse candidate for immunoglobulin D. Nature (1976) 1.38
Phenotypic classification of porcine lymphocyte subpopulations in blood and lymphoid tissues. Immunology (1996) 1.33
Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis. Parasite Immunol (1989) 1.32
Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol (1995) 1.31
Differential diagnosis of Taenia saginata and Taenia solium infection by PCR. J Clin Microbiol (2000) 1.31
Structure of mouse Fc receptor. Eur J Immunol (1977) 1.30
Biosynthesis of the carbohydrate portions of immunoglobulin M. Biochem J (1971) 1.29
Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol (1993) 1.25
A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels. J Immunol (1993) 1.25
Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology (1986) 1.24
Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg (1990) 1.22
Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides. J Immunol (1992) 1.21
A model for the differentiation of B lymphocytes with implications for the biological role of IgD. Immunol Rev (1977) 1.20
Biosynthesis of immunoglobulin A (IgA) and immunoglobulin M (IgM). Requirement for J chain and a disulphide-exchanging enzyme for polymerization. Biochem J (1973) 1.19
Primary diagnosis of foot-and-mouth disease by reverse transcription polymerase chain reaction. J Virol Methods (2000) 1.19
Biosynthetic units of an immunoglobulin heavy chain. Proc Natl Acad Sci U S A (1967) 1.18
Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg (2001) 1.17
A study of self-esteem among well adolescents: seeking a new direction. Issues Compr Pediatr Nurs (1999) 1.17
Biosynthesis of immunoglobulin A (IgA). Secretion and addition of carbohydrate to monomer and polymer forms of a mouse myeloma protein. Biochem J (1973) 1.17
Failure of cytochalasin or colchicine to inhibit secretion of immunoglobulins. Nat New Biol (1972) 1.17
Intracellular J chain in mouse plasmacytomas secreting IgA, IgM and IgG. Nature (1974) 1.16
Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis (1988) 1.16
The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. J Gen Virol (2001) 1.15
An urban community-based cancer prevention screening and health education intervention in Chicago. Public Health Rep (1990) 1.15
Evaluating Chicago's success in reaching the Healthy People 2000 goal of reducing health disparities. Public Health Rep (2002) 1.14
Mouse immunoglobulin receptors on lymphocytes: identification of IgM and IgD molecules by tryptic cleavage and a postulated role for cell surface IgD. Eur J Immunol (1977) 1.13
Papain sensitivity of heavy chain sub-classes in normal human IgG and localizaton of antigenic determinants for the sub-classes. Immunochemistry (1971) 1.12
Federal anti-patient-dumping provisions: the first decade. Ann Emerg Med (1996) 1.12
Selective stimulation of IgM synthesis in mouse B lymphocytes by pokeweed mitogen. Nat New Biol (1972) 1.12
Design of primers and use of RT-PCR assays for typing European bluetongue virus isolates: differentiation of field and vaccine strains. J Gen Virol (2007) 1.11
A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens. J Virol Methods (1985) 1.11
Characterization of surface antigens of Trichinella spiralis infective larvae. Parasite Immunol (1981) 1.11
New approaches in the diagnosis of Taenia solium cysticercosis and taeniasis. Ann Parasitol Hum Comp (1990) 1.10
Variation between centres in access to renal transplantation in UK: longitudinal cohort study. BMJ (2010) 1.10
Characterization of murine colony-forming B cells. I. Distribution, resistance to anti-immunoglobulin antibodies, and expression of Ia antigens. J Immunol (1978) 1.09
Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation. J Immunol (1998) 1.08
Biosynthesis of immunoglobulins. Prog Biophys Mol Biol (1972) 1.07
Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J Immunol (2000) 1.06
Expression cloning of a cDNA encoding a novel murine B cell activation marker. Homology to human CD38. J Immunol (1993) 1.05
Do chart reviews and interviews provide the same information about breast and cervical cancer screening? Int J Epidemiol (1993) 1.04
CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Int Immunol (1995) 1.04
Current chronic kidney disease practice patterns in the UK: a national survey. QJM (2006) 1.03
B cell subpopulations in the mouse: analysis with monoclonal antibodies NIM-R2 and NIM-R3. Eur J Immunol (1982) 1.03
Assembly of African Swine fever virus: quantitative ultrastructural analysis in vitro and in vivo. Virology (1996) 1.03
Referral adherence in an inner city breast and cervical cancer screening program. Cancer (1993) 1.02
Linkage of a major quantitative trait locus to Yaa gene-induced lupus-like nephritis in (NZW x C57BL/6)F1 mice. Eur J Immunol (1998) 1.02
T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol (1989) 1.01
Differential diagnosis of Taenia saginata and Taenia solium with DNA probes. Parasitology (1990) 1.01
Location of nucleotide pyrophosphatase and alkaline phosphodiesterase activities on the lymphocyte surface membrane. Biochem J (1976) 1.00
African swine fever: a disease characterized by apoptosis. J Gen Virol (1998) 0.99
Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells. Eur J Immunol (1995) 0.99
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors. J Immunol (1998) 0.99
Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule. J Immunol (1992) 0.98
A phosphorylcholine-containing filarial nematode-secreted product disrupts B lymphocyte activation by targeting key proliferative signaling pathways. J Immunol (1998) 0.98
International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine (1996) 0.98
Immunoglobulin M receptors on memory cells of immunoglobulin G antibody-forming cell clones. Eur J Immunol (1976) 0.98
Signalling in B cells. Immunol Today (1991) 0.98
Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus. J Gen Virol (1999) 0.97
The generation and persistence of genetic variation in foot-and-mouth disease virus. Prev Vet Med (2001) 0.97
Biosynthesis of J-chain in mouse IgA and IgM. Nat New Biol (1972) 0.96
Murine CD38: an immunoregulatory ectoenzyme. Immunol Today (1995) 0.96
Genetic relationships between foot-and-mouth disease type Asia 1 viruses. Epidemiol Infect (1994) 0.96
Social deprivation and survival on renal replacement therapy in England and Wales. Kidney Int (2006) 0.95
Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res (1998) 0.95
Differential expression of CD8 epitopes amongst porcine CD8-positive functional lymphocyte subsets. Immunology (1997) 0.95
A comparative study of the spiritual perspectives and interventions of mental health and parish nurses. Issues Ment Health Nurs (2001) 0.95
Mechanism and subcellular localization of secretory IgM polymer assembly. J Biol Chem (1994) 0.94
Surface immunoglobulins on the lymphocytes of the skate Raja naevus. Eur J Immunol (1975) 0.94
J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5. Proc Natl Acad Sci U S A (1992) 0.94
Bluetongue virus replication, molecular and structural biology. Vet Ital (2010) 0.94
Patterns of breast and cervical cancer screening at three public health centers in an inner-city urban area. Am J Public Health (1991) 0.94
Preparation of monoclonal anti-porcine CD3 antibodies and preliminary characterization of porcine T lymphocytes. Immunology (1996) 0.94
Electron microscopy of human and mouse myeloma serum IgA. J Mol Biol (1971) 0.94
Trends in adult renal replacement therapy in the UK: 1982-2002. QJM (2005) 0.94
Electron microscopy of complexes between IgA (MOPC 315) and a bifunctional hapten. J Mol Biol (1971) 0.93
African swine fever virus gene j13L encodes a 25-27 kDa virion protein with variable numbers of amino acid repeats. J Gen Virol (1995) 0.93
Rapid binding test for detection of alloantibodies to lymphocyte surface antigens. Curr Top Microbiol Immunol (1978) 0.93
Taenia saginata and Taenia solium: reciprocal models. Acta Leiden (1989) 0.93